Visfatin serum levels are increased in women with preeclampsia: A case-control study
- 18 February 2012
- journal article
- research article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 25 (9) , 1668-1673
Abstract
Objective: Visfatin has been implicated in the pathogenesis of preeclampsia with limited and contradictory, however, results. The aim of this study was to investigate the potential association between visfatin serum concentration and preeclampsia. Methods: Visfatin was determined in the serum of 38 women with preeclampsia and 38 women with uncomplicated pregnancies, matched for age and gestational age. Results: Similar baseline characteristics were present between the two groups in terms of age, body mass index, parity and gravidity. Serum visfatin was significantly increased in the preeclamptic women (median = 10.3 ng/mL; interquartile range [IQR] = 20) as opposed to their matched controls (median = 2.6 ng/mL; IQR = 1.4) (p < 0.001). Univariate analysis revealed a strong linear correlation of visfatin levels with systolic (r = 0.505, p < 0.001), diastolic (r = 0.467, p < 0.001) and mean arterial blood pressure (r = 0.497, p < 0.001), as well as with uric acid concentrations in the serum (r = 0.463, p < 0.001). A receiver operating characteristics curve analysis illustrated that serum visfatin concentration is helpful in discriminating between preeclamptic or nonpreeclamptic women with an area under the curve of 0.887 (95% confidence interval [CI]: 0.794–0.948; p < 0.001). Conclusion: Visfatin serum concentration seems to be increased in preeclampsia as compared with uncomplicated pregnancy.Keywords
This publication has 49 references indexed in Scilit:
- Uric AcidHypertension, 2011
- Evidence for visfatin as an independent predictor of endothelial dysfunction in polycystic ovary syndromeClinical Endocrinology, 2011
- Maternal and neonatal circulating visfatin concentrations in patients with pre-eclampsia and a small-for-gestational age neonateThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?The Journal of Maternal-Fetal & Neonatal Medicine, 2009
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During PreeclampsiaHypertension, 2008
- Potential Roles of Angiotensin Receptor-Activating Autoantibody in the Pathophysiology of PreeclampsiaHypertension, 2007
- PreeclampsiaHypertension, 2005
- Generation of Reactive Oxygen Species by Neutrophils and Endothelial Cell Injury in Normal and Preeclamptic PregnanciesHypertension, 2005
- Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular DysfunctionMicrocirculation, 2002